Welcome to I.ON, the on-demand digital immunology programme designed to provide rheumatologists, dermatologists, immunologists and allergists treating PsO, chronic spontaneous urticaria, psoriatic arthritis and axial spondyloarthritis with first-class, digital, medical educational content.

This page allows you to access information on CSU, including what it is, the burden it places on patients, what a patient with CSU may look like, CSU management guidelines and patient-reported outcome measures. Please click on the links below to access the information you want.


CSU, chronic spontaneous urticaria; PsO, psoriasis.

Rate this content: 
No votes yet
UK | October 2021 | 146364

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]